| Literature DB >> 33721486 |
Jii Bum Lee1, Minkyu Jung1,2, June Hyuk Kim3, Bo Hyun Kim4, Yeol Kim5, Young Seok Kim6, Byung Chang Kim7, Jin Kim8, Sung Ho Moon9, Keon-Uk Park10, Meerim Park11, Hyeon Jin Park11, Sung Hoon Sim12, Hong Man Yoon13, Soo Jung Lee14, Eunyoung Lee15, June Young Chun16, Youn Kyung Chung17, So-Youn Jung12, Jinsoo Chung18, Eun Sook Lee12, Hyun Cheol Chung1,2, Tak Yun19, Sun Young Rha1,2.
Abstract
At the end of 2019, the cause of pneumonia outbreaks in Wuhan, China, was identified as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In February 2020, the World Health Organization named the disease cause by SARS-CoV-2 as coronavirus disease 2019 (COVID-19). In response to the pandemic, the Korean Cancer Association formed the COVID-19 task force to develop practice guidelines. This special article introduces the clinical practice guidelines for cancer patients which will help oncologists best manage cancer patients during the COVID-19 pandemic.Entities:
Keywords: COVID-19; Cancer care; Guideline; Korea
Mesh：
Year: 2021 PMID： 33721486 DOI： 10.4143/crt.2020.1256
Source DB: PubMed Journal: Cancer Res Treat ISSN： 1598-2998 Impact factor: 4.679